Psoriasis (Auckl) 6:131144 Betz D, Fane K (2018)
Biohacker Protocol (experimental) Dose: 0.1 0.2 mg (= 48 clicks) Duration: 8 12 weeks Frequency: 2 per week Cycle Interval: 2 4 weeks off before repeating Goal / Description: Lower-dose continuous design exploring sustained anabolic signaling
Oxford University Press, USA Harvell CD, Kim K, Burkholder JM, Colwell RR, Epstein PR, Grimes DJ, Hoffman EE, Lipp EK, Osterhaus ADME, Overstreet RM, Porter JW, Smith GW, Vasta GR (1999) Emerging marine diseasesclimate links and anthropogenic factors
SEP-479 oral small-molecule agonist of the parathyroid hormone 1 receptor (PTH1R) aimed at treating hypoparathyroidism Recent Highlights: In May 2025, Septerna signed an exclusive global collaboration with Novo Nordisk worth up to $2.2B to co-develop oral small molecule GLP-1, GIP, and glucagon receptor agonists
Monitor your body composition to ensure your muscle mass is being preserved
Inhibition of GGT inhibits the activity of the Xc - system and thus promotes ferroptosis